Gene · 2813
NIH grants1,628
NIH grants whose papers are about the gene, through NIH's grant-paper links.
841 to 860 of 1,628
Download this page as JSON| Grant | Title | GP2 papers | Newest fiscal year |
|---|---|---|---|
| R01GM102611 | Enantioselective Catalysis with Cyclopropenimines | 1 | 2017 |
| R01GM103600 | Proteogenomic analysis of inflammation and dysbiosis in the infant gut | 1 | 2017 |
| R01GM103833 | Quantitative Analysis and Modeling of Microtubule Structure and Regulation | 1 | 2017 |
| R01GM109199 | Functional Profiling of Human Disease Targets | 1 | 2017 |
| R01HL109319 | CVD in American Indians Biomarker lab and Arizona Field Center | 1 | 2017 |
| R01HL116455 | A Bioengineering Approach to Gene Therapy for Peripheral Arterial Disease | 1 | 2017 |
| R01HL121635 | MicroRNA 93 in Peripheral Arterial Disease | 1 | 2017 |
| R01HL124444 | Skeletal Muscle and Vascular Remodeling in Peripheral Artery Disease | 1 | 2017 |
| R01MH100999 | Therapeutics Targeting Macrophages/Microglia to Eradicate CNS HIV-1 Reservoirs | 1 | 2017 |
| R01MH104680 | Integration of brain imaging with genomic and epigenomic data | 1 | 2017 |
| R03DK110497 | Interplay Between Stem Cells and Inflammation in Benign Prostatic Hyperplasia | 1 | 2017 |
| R15CA202984 | Oncolytic reovirus modulation of the cancer cell hypoxic response | 1 | 2017 |
| R21AI117300 | Development of novel protease inhibitors for influenza and paramyxoviruses | 1 | 2017 |
| R21AI122256 | Mechanism of Humoral Immune Defects in Autoimmune Polyglandular Syndrome Type 1 | 1 | 2017 |
| R21AI123920 | Structural mechanism for recognition of host receptor by botulinum neurotoxin A | 1 | 2017 |
| R21AI127351 | A radiation-induced cellular stress activates HIV and induces killing of infected cells | 1 | 2017 |
| R21AI129306 | Structure-based Design of Zika Virus Inhibitors Targeting Envelope Glycoprotein (E) | 1 | 2017 |
| R43AI129082 | Direct sequencing of serum antibodies after infection | 1 | 2017 |
| R44DK105655 | technologyIn vitro maturation of BMP-7-responsive pancraeatic beta cell progenitors by oxygen modulation | 1 | 2017 |
| R56AI063426 | M cell induction and function in mucosal tissues | 1 | 2017 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2813/grants?page=43